Zohar Ben Dov Net Worth

The estimated Net Worth of Zohar Ben Dov is at least $855 mil dollars as of 28 December 2012. Zohar Dov owns over 22,693 units of Spero Therapeutics Inc stock worth over $855,267 and over the last 13 years Zohar sold SPRO stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Zohar Dov SPRO stock SEC Form 4 insiders trading

Zohar has made over 4 trades of the Spero Therapeutics Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Zohar bought 22,693 units of SPRO stock worth $27,005 on 28 December 2012.

The largest trade Zohar's ever made was buying 55,407 units of Spero Therapeutics Inc stock on 1 December 2011 worth over $108,044. On average, Zohar trades about 29,540 units every 144 days since 2011. As of 28 December 2012 Zohar still owns at least 638,259 units of Spero Therapeutics Inc stock.

You can see the complete history of Zohar Dov stock trades at the bottom of the page.

What's Zohar Dov's mailing address?

Zohar's mailing address filed with the SEC is 2125 Hatchers Mill Rd, Scott, VA, USA.

Insiders trading at Spero Therapeutics Inc

Over the last 15 years, insiders at Spero Therapeutics Inc have traded over $15,920,732 worth of Spero Therapeutics Inc stock and bought 3,223,281 units worth $44,767,755 . The most active insiders traders include Plc Gsk, Jean Francois Formela y Capital Management, Llc Aqu.... On average, Spero Therapeutics Inc executives and independent directors trade stock every 71 days with the average trade being worth of $122,858. The most recent stock trade was executed by Ankit Mahadevia on 27 August 2024, trading 5,912 units of SPRO stock currently worth $7,981.

What does Spero Therapeutics Inc do?

spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.

Complete history of Zohar Dov stock trades at Spero Therapeutics Inc

Spero Therapeutics Inc executives and stock owners

Spero Therapeutics Inc executives and other stock owners filed with the SEC include:

• Ankit Mahadevia,
  President, Chief Executive Officer, Director
• Dr. Ankit Mahadevia M.D., MBA,
  Co-Founder, CEO, Pres & Director
• Cristina Larkin,
  Chief Operating Officer and Chief Commercial Officer
• David Melnick,
  Cheif Medical Officer
• Dr. David A. Melnick M.D.,
  Chief Medical Officer
• Cristina Larkin,
  Chief Operating Officer
• Thomas Parr,
  Chief Scientific Officer
• Cynthia Smith,
  Independent Director
• Milind Deshpande,
  Independent Chairman of the Board
• Frank Thomas,
  Independent Director
• Patrick Vink,
  Independent Director
• John Pottage,
  Independent Director
• Jean-Francois Formela,
  Independent Director
• Sharon Klahre,
  IR Contact Officer
• Scott Jackson,
  Independent Director
• Timothy Keutzer,
  Chief Development Officer
• Stephen DiPalma,
  Chief Financial Officer, Treasurer
• Timothy Keutzer,
  Chief Devel. Officer
• James P. Brady,
  Chief Human Resource Officer
• David Musselman,
  Sr. VP of Sales & Market Access
• Tamara Lynn Joseph L.L.M., J.D.,
  Chief Legal Officer
• Ted Jenkins,
  VP & Head of Investor Relations
• Dr. Thomas R. Parr Jr., Ph.D.,
  Chief Scientific Officer
• Satyavrat Shukla C.F.A.,
  Chief Financial Officer
• David P Southwell,
  Director
• John J Gorman,
  Director
• Jack Fingerhut,
  President
• Allen S Greene,
  Chairman of the Board and CEO
• Lager H Martin,
  Director
• Joel Sendek,
  Chief Financial Officer
• Plc Gsk,
  10% owner
• Joseph R Fish,
  EVP & Chief Technology Officer
• Leonard J Stanley,
  Director
• Vikas Goyal,
  Director
• Casper Breum,
  Director
• Stanley P Wirtheim,
  Chief Financial Officer
• Zohar Ben Dov,
  10% owner
• Esther Rajavelu,
  See Remarks
• Capital Management, Llc Aqu...,
  
• Kathleen Tregoning,
  
• Kamal Hamed,
  Chief Medical Officer
• Sath Shukla,
  CEO & President
• Tamara L Joseph,
  Chief Legal Officer